IAV207-2 Influenza A NCP Antibody Inhibition ELISA - Photometric

Search for all "Influenza A NCP Antibody Inhibition ELISA - Photometric"

2 x 96 Tests / €800.00
Please visit the country specific website of Acris Antibodies or contact your local Distributor to buy this product.

Product Description for Influenza A NCP Antibody Inhibition ELISA - Photometric

Product is tested for Western blot / Immunoblot, Immunocytochemistry/Immunofluorescence.

Properties for Influenza A NCP Antibody Inhibition ELISA - Photometric

Product Category ELISA Kits
Quantity 2 x 96 Tests
Shipping to Worldwide
PDF datasheet View Datasheet
Manufacturer Virusys Corporation

Datasheet Extract

Background Influenza viruses can be divided into three classes, A, B, and C, largely based upon conserved antigenic differences in the internal nucleoprotein. Influenza A virus, typically encountered more frequently than types B and C, and associated with the majority of serious epidemics, can be further subdivided into strains or subtypes based on antigenic differences in the external hemagglutinin proteins (H1-H16) and neuraminidase proteins (N1-N9). 
A variety of wild waterfowl appear to be the predominant natural reservoir for Influenza A viruses and subtypes representing most of the hemagglutinin and neuraminidase combinations can be found circulating in these birds. Historically, human influenza virus infections have been associated with H1N1, H2N2, and H3N2 subtypes of influenza A, although a recent (1997) and significant outbreak in Hong Kong was identified as an H5N1 subtype. This outbreak was not only significant because it resulted in 18 human infections and 6 deaths, but it also represented the first known demonstration of avian influenza virus transmission to humans. 
Depending upon the serological requirements or research interest (natural infection, vaccine monitoring, or DIVA [Differentiation of Infected from Vaccinated Animals]), it may be useful to monitor the development of influenza A NP-specific antibody in a variety of species. Virusys has developed a highly sensitive and specific enzyme-linked immunosorbent assay (ELISA) for the detection of influenza A NP-specific antibodies in serum from human and veterinary sources. Because the assay utilizes "inhibition of binding" technology, it may be used with serum from any species, and therefore does not require species-specific conjugates. The assay can be completed in less than 1.5 hr., contains only one wash step, and incorporates proprietary diluents that are designed to prevent the development of nonspecific signal derived from sample matrix and/or the nonspecific adsorption of reactive test components. The result is an assay that is both highly sensitive and specific. 

Recent publications:

Canine Influenza (H3N8) in the Rocky Mountain Region

Recently Emerged Swine Influenza A Virus (H2N3) Causes Severe Pneumonia in Cynomolgus Macaques

Influenza Virus Infection in Nonhuman Primates

  • LinkedIn